These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 6778528)
61. Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase. Gregoriadis G; Neerunjun D; Meade TW; Goolamali SK; Weereratne H; Bull G Birth Defects Orig Artic Ser; 1980; 16(1):383-92. PubMed ID: 6778529 [No Abstract] [Full Text] [Related]
62. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model. Gregoriadis G; Weereratne H; Blair H; Bull GM Prog Clin Biol Res; 1982; 95():681-701. PubMed ID: 6812092 [No Abstract] [Full Text] [Related]
63. Status of enzyme replacement therapy for Gaucher disease. Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519 [TBL] [Abstract][Full Text] [Related]
64. [Gaucher's disease: results of enzymatic treatment with beta glucosidase acid]. Genovés Terol I; Martínez Porcal C; Ferrrer Lorente B; Menor Serrano F; Dalmau Serra J An Esp Pediatr; 1997 Apr; 46(4):406-8. PubMed ID: 9214240 [No Abstract] [Full Text] [Related]
65. New directions in the treatment of Gaucher disease. Futerman AH; Sussman JL; Horowitz M; Silman I; Zimran A Trends Pharmacol Sci; 2004 Mar; 25(3):147-51. PubMed ID: 15019270 [No Abstract] [Full Text] [Related]
66. Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Gregoriadis G Ann N Y Acad Sci; 1978; 308():343-70. PubMed ID: 100040 [No Abstract] [Full Text] [Related]
67. Current issues in enzyme therapy for Gaucher disease. Grabowski GA Drugs; 1996 Aug; 52(2):159-67. PubMed ID: 8841735 [TBL] [Abstract][Full Text] [Related]